Skip to main content
HairCited

Female-pattern hair loss: therapeutic update.

Paulo Müller Ramos, Daniel Fernandes Melo, Henrique Radwanski, Rita Fernanda Cortez de Almeida, Hélio Amante Miot
Review Anais brasileiros de dermatologia 2023 29 citações
PubMed DOI CC-BY PDF
<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D37003900'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Tipo de Estudo
Review
Intervenção
Female-pattern hair loss: therapeutic update. topical minoxidil (first-line); various other therapies reviewed
Comparador
Placebo
Direção do Efeito
Mixed
Risco de Viés
Unclear

Abstract

Female androgenetic alopecia or female-pattern hair loss (FPHL) is highly prevalent and has a great impact on the quality of life. The treatment is a routine challenge in dermatological practice, as many therapeutic options have a limited level of evidence and often do not meet patients expectations. Lack of knowledge of the pathogenesis of the hair miniaturization process and the factors that regulate follicular morphogenesis restricts the prospect of innovative therapies. There is also a lack of randomized, controlled studies with longitudinal follow-up, using objective outcomes and exploring the performance of the available treatments and their combinations. Topical minoxidil, which has been used to treat female pattern hair loss since the 1990s, is the only medication that has a high level of evidence and remains the first choice. However, about 40% of patients do not show improvement with this treatment. In this article, the authors critically discuss the main clinical and surgical therapeutic alternatives for FPHL, as well as present camouflage methods that can be used in more extensive or unresponsive cases.

Full Text

PDF
Loading PDF...

Figures

References

  1. Untitled
  2. Untitled
  3. Untitled
  4. Untitled
  5. Untitled
  6. Untitled
  7. Untitled
  8. Untitled
  9. Untitled
  10. Untitled
  11. Untitled
  12. Untitled
  13. Untitled
  14. Untitled
  15. Untitled
  16. Untitled
  17. Untitled
  18. Untitled
  19. Untitled
  20. Untitled
  21. Untitled
  22. Untitled
  23. Untitled
  24. Untitled
  25. Untitled
  26. Untitled
  27. Untitled
  28. Untitled
  29. Untitled
  30. Untitled
  31. Untitled
  32. Untitled
  33. Untitled
  34. Untitled
  35. Untitled
  36. Untitled
  37. Untitled
  38. Untitled
  39. Untitled
  40. Untitled
  41. Untitled
  42. Untitled
  43. Untitled
  44. Untitled
  45. Untitled
  46. Untitled
  47. Untitled
  48. Untitled
  49. Untitled
  50. Untitled
  51. Untitled
  52. Untitled
  53. Untitled
  54. Untitled
  55. Untitled
  56. Untitled
  57. Untitled
  58. Untitled
  59. Untitled
  60. Untitled
  61. Untitled
  62. Untitled
  63. Untitled
  64. Untitled
  65. Untitled
  66. Untitled
  67. Untitled
  68. Untitled
  69. Untitled
  70. Untitled
  71. Untitled
  72. Untitled
  73. Untitled
  74. Untitled
  75. Untitled
  76. Untitled
  77. Untitled
  78. Untitled
  79. Untitled
  80. Untitled
  81. Untitled
  82. Untitled
  83. Untitled
  84. Untitled
  85. Untitled
  86. Untitled

Used In Evidence Reviews

Similar Papers